Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 12 | 2020 | 893 | 2.320 |
Why?
|
| Alcoholism | 6 | 2020 | 1109 | 1.630 |
Why?
|
| Alcohol Drinking | 6 | 2020 | 805 | 1.190 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 3 | 2017 | 51 | 1.050 |
Why?
|
| Central Nervous System Depressants | 5 | 2016 | 182 | 1.030 |
Why?
|
| Corticosterone | 3 | 2014 | 51 | 1.000 |
Why?
|
| Prefrontal Cortex | 3 | 2020 | 640 | 1.000 |
Why?
|
| Receptors, AMPA | 2 | 2016 | 99 | 0.920 |
Why?
|
| Amygdala | 3 | 2016 | 159 | 0.900 |
Why?
|
| Action Potentials | 2 | 2020 | 223 | 0.720 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 2 | 2017 | 27 | 0.690 |
Why?
|
| Conditioning, Operant | 5 | 2015 | 241 | 0.610 |
Why?
|
| Potassium Channels | 1 | 2018 | 55 | 0.600 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 274 | 0.590 |
Why?
|
| Long-Term Potentiation | 1 | 2017 | 53 | 0.560 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2016 | 26 | 0.530 |
Why?
|
| Extinction, Psychological | 1 | 2017 | 240 | 0.500 |
Why?
|
| Drug-Seeking Behavior | 2 | 2018 | 213 | 0.500 |
Why?
|
| Stress, Psychological | 2 | 2020 | 824 | 0.490 |
Why?
|
| Discrimination Learning | 2 | 2011 | 45 | 0.480 |
Why?
|
| Receptors, Nicotinic | 2 | 2016 | 41 | 0.470 |
Why?
|
| Nucleus Accumbens | 3 | 2015 | 417 | 0.450 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 2011 | 75 | 0.450 |
Why?
|
| Rats | 10 | 2017 | 5300 | 0.440 |
Why?
|
| Glutamates | 1 | 2012 | 41 | 0.430 |
Why?
|
| Neurons | 1 | 2018 | 881 | 0.400 |
Why?
|
| Animals | 15 | 2020 | 20881 | 0.390 |
Why?
|
| Rats, Long-Evans | 6 | 2016 | 203 | 0.390 |
Why?
|
| Sucrose | 4 | 2016 | 58 | 0.370 |
Why?
|
| Self Administration | 5 | 2016 | 419 | 0.350 |
Why?
|
| Mediodorsal Thalamic Nucleus | 1 | 2009 | 3 | 0.340 |
Why?
|
| Nicotinic Antagonists | 1 | 2009 | 11 | 0.340 |
Why?
|
| Motor Activity | 5 | 2018 | 621 | 0.290 |
Why?
|
| Cognition | 1 | 2009 | 513 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 2791 | 0.250 |
Why?
|
| Male | 13 | 2020 | 37321 | 0.230 |
Why?
|
| Analysis of Variance | 4 | 2015 | 1040 | 0.220 |
Why?
|
| Nicotinic Agonists | 2 | 2016 | 111 | 0.210 |
Why?
|
| Mice | 4 | 2020 | 8474 | 0.190 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2020 | 87 | 0.180 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 187 | 0.180 |
Why?
|
| Nicotine | 2 | 2016 | 350 | 0.170 |
Why?
|
| Rats, Wistar | 2 | 2018 | 371 | 0.170 |
Why?
|
| Random Allocation | 1 | 2020 | 442 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 1745 | 0.170 |
Why?
|
| Antipsychotic Agents | 2 | 2013 | 247 | 0.160 |
Why?
|
| KCNQ Potassium Channels | 1 | 2018 | 8 | 0.160 |
Why?
|
| Ventral Tegmental Area | 1 | 2018 | 74 | 0.150 |
Why?
|
| Alcohol-Related Disorders | 1 | 2018 | 95 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2550 | 0.140 |
Why?
|
| Excitatory Amino Acid Agents | 2 | 2014 | 20 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2017 | 79 | 0.140 |
Why?
|
| Conditioning, Classical | 1 | 2016 | 57 | 0.130 |
Why?
|
| Varenicline | 1 | 2016 | 98 | 0.130 |
Why?
|
| Reinforcement Schedule | 2 | 2013 | 59 | 0.130 |
Why?
|
| Linear Models | 2 | 2015 | 521 | 0.120 |
Why?
|
| Phenylacetates | 1 | 2014 | 18 | 0.120 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2011 | 64 | 0.120 |
Why?
|
| Amino Acids | 2 | 2011 | 131 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 114 | 0.110 |
Why?
|
| Glycine | 1 | 2014 | 89 | 0.110 |
Why?
|
| Butyrophenones | 1 | 2013 | 2 | 0.110 |
Why?
|
| Drinking Behavior | 1 | 2013 | 20 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2016 | 470 | 0.110 |
Why?
|
| Benzamides | 1 | 2014 | 156 | 0.110 |
Why?
|
| Pyrrolidinones | 1 | 2012 | 15 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2014 | 190 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2016 | 1200 | 0.110 |
Why?
|
| Nootropic Agents | 1 | 2012 | 18 | 0.110 |
Why?
|
| Drug Interactions | 2 | 2011 | 289 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2012 | 78 | 0.100 |
Why?
|
| Cues | 2 | 2016 | 654 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2014 | 279 | 0.100 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2012 | 128 | 0.100 |
Why?
|
| Alcohols | 1 | 2011 | 13 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 147 | 0.100 |
Why?
|
| Recurrence | 1 | 2012 | 948 | 0.090 |
Why?
|
| Anxiety | 1 | 2013 | 422 | 0.090 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2009 | 5 | 0.090 |
Why?
|
| Aconitine | 1 | 2009 | 5 | 0.090 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2009 | 9 | 0.090 |
Why?
|
| Clozapine | 1 | 2009 | 46 | 0.080 |
Why?
|
| Maze Learning | 1 | 2009 | 138 | 0.080 |
Why?
|
| Microinjections | 3 | 2015 | 130 | 0.080 |
Why?
|
| Memory | 1 | 2009 | 214 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2016 | 2689 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 1242 | 0.060 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 2083 | 0.060 |
Why?
|
| Alcohol Deterrents | 1 | 2018 | 86 | 0.040 |
Why?
|
| Female | 3 | 2018 | 38074 | 0.030 |
Why?
|
| Dopamine | 1 | 2018 | 474 | 0.030 |
Why?
|
| Apamin | 1 | 2015 | 13 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 32 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 35 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 63 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 166 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 786 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2015 | 204 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2015 | 85 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2015 | 218 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 765 | 0.030 |
Why?
|
| Humans | 2 | 2018 | 68618 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 190 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 236 | 0.030 |
Why?
|
| Butadienes | 1 | 2011 | 26 | 0.030 |
Why?
|
| Nitriles | 1 | 2011 | 68 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 306 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 175 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2009 | 23 | 0.020 |
Why?
|
| Food Preferences | 1 | 2009 | 46 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2009 | 396 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 659 | 0.020 |
Why?
|
| Pyridines | 1 | 2009 | 261 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2016 | 1034 | 0.020 |
Why?
|